Frankie L. Stinson

Array ( [id] => 9704119 [patent_doc_number] => 08829183 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-09-09 [patent_title] => 'Method for forming cooperative binary ionic solids' [patent_app_type] => utility [patent_app_number] => 13/758469 [patent_app_country] => US [patent_app_date] => 2013-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3365 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13758469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866656 [patent_doc_number] => 20130150358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'THERAMUTEIN MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/758422 [patent_app_country] => US [patent_app_date] => 2013-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27225 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13758422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9835097 [patent_doc_number] => 20150027179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'SYNGAS BIOMETHANATION PROCESS AND ANAEROBIC DIGESTION SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/373714 [patent_app_country] => US [patent_app_date] => 2013-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4561 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813126 [patent_doc_number] => 20150025071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'TETRAHYDRO-QUINAZOLINONE DERIVATIVES AS TANK AND PARP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/378009 [patent_app_country] => US [patent_app_date] => 2013-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20461 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902097 [patent_doc_number] => 20150057297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'HALOFUGINOL DERIVATIVES AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/371934 [patent_app_country] => US [patent_app_date] => 2013-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 32218 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039200 [patent_doc_number] => 09079898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors' [patent_app_type] => utility [patent_app_number] => 13/725407 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32222 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13725407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892470 [patent_doc_number] => 20130165653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device' [patent_app_type] => utility [patent_app_number] => 13/716811 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 41603 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13716811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567323 [patent_doc_number] => 09290480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same' [patent_app_type] => utility [patent_app_number] => 13/710543 [patent_app_country] => US [patent_app_date] => 2012-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14798 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13710543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780624 [patent_doc_number] => 20130102599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'PYRAZOLO [4,3-C] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/710513 [patent_app_country] => US [patent_app_date] => 2012-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32533 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13710513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10961405 [patent_doc_number] => 20140364435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES' [patent_app_type] => utility [patent_app_number] => 14/364181 [patent_app_country] => US [patent_app_date] => 2012-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42940 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11611468 [patent_doc_number] => 09649312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Compositions and methods of treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/708820 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16751 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9896192 [patent_doc_number] => 20150051392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'FUNCTIONALISATION OF CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 14/363242 [patent_app_country] => US [patent_app_date] => 2012-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12112 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10155673 [patent_doc_number] => 09187430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Poly (ADP-ribose) polymerase inhibitor' [patent_app_type] => utility [patent_app_number] => 14/361698 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32092 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842082 [patent_doc_number] => 20130137711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'POLYMORPH FORMS OF 4-ANILINOQUINAZOLINE DERIVATIVES, THE PREPARATION METHODS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/680330 [patent_app_country] => US [patent_app_date] => 2012-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11112 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594436 [patent_doc_number] => 09315511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound' [patent_app_type] => utility [patent_app_number] => 14/358423 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13112 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823603 [patent_doc_number] => 08933088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide' [patent_app_type] => utility [patent_app_number] => 13/669564 [patent_app_country] => US [patent_app_date] => 2012-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8425 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13669564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094941 [patent_doc_number] => 20130274252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/667489 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7096 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13667489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699453 [patent_doc_number] => 20140249139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'Quinazoline Derivatives' [patent_app_type] => utility [patent_app_number] => 14/352055 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45724 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11779066 [patent_doc_number] => 09388160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Quinazoline derivatives as kinases inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/351557 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7077 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9408943 [patent_doc_number] => 20140100195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Heterobicyclic sphingosine 1-phosphate analogs' [patent_app_type] => utility [patent_app_number] => 13/646143 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34628 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646143 [rel_patent_id] =>[rel_patent_doc_number] =>)